ELI LILLY AND COMPANY Undistributed Earnings of Foreign Subsidiaries
ELI LILLY AND COMPANY (LLY) had Undistributed Earnings of Foreign Subsidiaries of $28.00 billion as of 2016-12-31, per its 10-K filed 2017-02-21.
Discontinued › Notes › Income Taxes
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2017-02-21
- 2016-12-31: Undistributed Earnings of Foreign Subsidiaries $28.00B.
- 2015-12-31: Undistributed Earnings of Foreign Subsidiaries $26.50B.
- 2014-12-31: Undistributed Earnings of Foreign Subsidiaries $25.70B.
- 2013-12-31: Undistributed Earnings of Foreign Subsidiaries $23.74B.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2016-12-31 | $28.00B 10-K · filed 2017-02-21 |
| 2015-12-31 | $26.50B 10-K · filed 2016-02-19 |
| 2014-12-31 | $25.70B 10-K · filed 2015-02-19 |
| 2013-12-31 | $23.74B 10-K · filed 2014-02-19 |
| 2012-12-31 | $20.98B 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |